You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. HARROW HEALTH INC

Harrow Health Inc XNAS: HROW

Harrow Health Inc Live Share Price Today, Share Analysis and Chart

Weak Stock
Download real time

23.38 -0.61 (-2.54%)

60.53% Fall from 52W High

85,559 XNAS Volume

XNAS 21 Apr, 2025 11:12 AM (EDT)

Watchlist

Portfolio

Share

Harrow Health Inc Key Metrics

Default

Market Capitalization

Below industry Median
833.6

PE TTM

Negative PE TTM
-47.7

PEG TTM

Negative PEG TTM
-1.7

Price to Book

High in industry
12

Institutional holding current Qtr %

Below industry Median
58.8

Revenue Growth Qtr YoY %

High in industry
83.8

Operating Revenue growth TTM %

Below industry Median
53.3

Net Profit Qtr Growth YoY %

High in industry
174.1

Net Profit TTM Growth %

Below industry Median
28.4

Operating Profit Margin Qtr %

Below industry Median
19.7

Operating Profit Margin TTM %

Below industry Median
4.5

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

-30.8

ROE Annual %

Negative ROE Annual %
-24.9

RoA Annual %

Negative RoA Annual %
-5
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
10.5 / 100
Momentum Score
Technically Bearish
33.3 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
57
1Yr Price target upside is 146%
5 analysts

16

S

18

W

1

O

3

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Harrow Health Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '260250500Actual RevenueAvg. Estimate
Miss

Harrow Health Inc's Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

Current EPS
-0.5
Avg. Estimate
0.5
Low Estimate
0.2
High Estimate
0.8
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 200.0% in FY25

Consensus Recommendation

5 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.21Buy4Strong Buy

The consensus recommendation from 5 analysts for Harrow Health Inc is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Harrow Health Inc Stock Analysis

Harrow Health Inc stock analysis with key metrics, changes, and trends.

Harrow Health Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$199.61 M53.32%positive

Annual Revenue rose 53.32%, in the last year to $199.61 M. Its sector's average revenue growth for the last fiscal year was 7.54%.

Annual Net Profit$17.48 M28.39%positive

Annual Net Profit rose 28.39% in the last year to $17.48 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

Price to Earning Ratio-47.69-negative

Price to Earning Ratio is -47.69, which is negative.

Stock Price$23.38123.73%positive

Stock Price rose 123.73% and outperformed its sector by 116.37% in the past year.

Quarterly Revenue$66.83 M83.83%positive

Quarterly Revenue rose 83.83% YoY to $66.83 M. Its sector's average revenue growth YoY for the quarter was 5.84%.

Quarterly Net profit$6.78 M174.08%positive

Quarterly Net profit rose 174.08% YoY to $6.78 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

Debt to Equity Ratio3.29-negative

Debt to Equity Ratio of 3.29 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)-24.90 %-24.9%negative

Return on Equity(ROE) for the last financial year was -24.9%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding31.65 %-0.1%negative

Mutual Fund Holding decreased by 0.1% in the last quarter to 31.65.

Promoter Share Holding15.27 %3.33%positive

Promoter Share Holding increased by 3.33% in the most recent quarter to 15.27%.

Interest Coverage Ratio0.24-negative

Interest Coverage Ratio is 0.24, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding58.77 %-0.25%negative

Institutional Holding decreased by 0.25% in the last quarter to 58.77.

VIEW LESS


Loading data..

Harrow Health Inc - Company Profile

What does Harrow Health Inc do?

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Harrow Health Inc Management structure

All Gross Remunerations are in USD
Mr. John Saharek
Chief Commercial Officer; President and Chief Executive Officer, ImprimisRx
-
2024
Gross Remuneration
Year
Mr. Mark L. Baum
Chief Executive Officer and Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. Andrew R. Boll
Chief Accounting Officer, Chief Financial Officer and Corporate Secretary
-
2024
Gross Remuneration
Year

Harrow Health Inc Board of directors

All Gross Remunerations are in USD
Dr. Martin A. Makary, M.D.
Independent Director
-
2025
Gross Remuneration
Year

Harrow Health Inc FAQ

How is Harrow Health Inc today?
Harrow Health Inc today is trading in the red, and is down by -2.54% at 23.38.
Harrow Health Inc is currently trading down -2.54% on an intraday basis. In the past week the stock fell -2.95%. stock has been down -30.93% in the past quarter and rose 123.73% in the past year. You can view this in the overview section.